[go: up one dir, main page]

EA200201006A1 - Технология приготовления таблеток оксазолидинона - Google Patents

Технология приготовления таблеток оксазолидинона

Info

Publication number
EA200201006A1
EA200201006A1 EA200201006A EA200201006A EA200201006A1 EA 200201006 A1 EA200201006 A1 EA 200201006A1 EA 200201006 A EA200201006 A EA 200201006A EA 200201006 A EA200201006 A EA 200201006A EA 200201006 A1 EA200201006 A1 EA 200201006A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxazolidinonone
tablets
preparation
technology
bioavailability
Prior art date
Application number
EA200201006A
Other languages
English (en)
Other versions
EA006772B1 (ru
Inventor
Гомер Лин
Кен Ямамото
Original Assignee
Фармация Энд Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22703542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200201006(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Фармация Энд Апджон Компани filed Critical Фармация Энд Апджон Компани
Publication of EA200201006A1 publication Critical patent/EA200201006A1/ru
Publication of EA006772B1 publication Critical patent/EA006772B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Настоящее изобретение предусматривает прессованную таблетку антибактериального оксазолидинонового агента, обеспечивающую высокую лекарственную нагрузку и биодоступность.Отчет о международном поиске был опубликован 2001.12.13.
EA200201006A 2000-03-22 2001-03-15 Прессованная таблетка на основе линезолида и ее применение EA006772B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19096900P 2000-03-22 2000-03-22
PCT/US2001/005812 WO2001070225A2 (en) 2000-03-22 2001-03-15 Oxazolidinone tablet formulation

Publications (2)

Publication Number Publication Date
EA200201006A1 true EA200201006A1 (ru) 2003-02-27
EA006772B1 EA006772B1 (ru) 2006-04-28

Family

ID=22703542

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200201006A EA006772B1 (ru) 2000-03-22 2001-03-15 Прессованная таблетка на основе линезолида и ее применение

Country Status (33)

Country Link
EP (1) EP1265608B1 (ru)
JP (1) JP2003527424A (ru)
KR (2) KR100786410B1 (ru)
CN (1) CN1208058C (ru)
AR (1) AR033357A1 (ru)
AT (1) ATE412413T1 (ru)
AU (2) AU4324301A (ru)
BG (1) BG107117A (ru)
BR (1) BR0108846A (ru)
CA (1) CA2400118A1 (ru)
CZ (1) CZ20023133A3 (ru)
DE (1) DE60136341D1 (ru)
DK (1) DK1265608T3 (ru)
EA (1) EA006772B1 (ru)
EC (1) ECSP013979A (ru)
ES (1) ES2312422T3 (ru)
HK (1) HK1054325B (ru)
HR (1) HRP20020765A2 (ru)
HU (1) HUP0300378A3 (ru)
IL (1) IL151788A0 (ru)
MX (1) MXPA02009316A (ru)
MY (1) MY136370A (ru)
NO (1) NO20024505L (ru)
NZ (1) NZ521525A (ru)
PE (2) PE20011126A1 (ru)
PL (1) PL201686B1 (ru)
PT (1) PT1265608E (ru)
SK (1) SK12092002A3 (ru)
TW (1) TWI293028B (ru)
UA (1) UA77654C2 (ru)
WO (1) WO2001070225A2 (ru)
YU (1) YU69802A (ru)
ZA (1) ZA200207073B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
AU2006277017A1 (en) * 2005-07-20 2007-02-15 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical composition comprising linezolid form IV
WO2010026597A1 (en) * 2008-09-02 2010-03-11 Hetero Research Foundation Oral dosage forms of linezolid and processes for their preparation
EP2642996B1 (en) * 2010-11-24 2020-09-23 Melinta Subsidiary Corp. Pharmaceutical compositions
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
CN103505459B (zh) * 2012-06-20 2016-02-24 北京万生药业有限责任公司 利奈唑胺药物组合物
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
PT3277270T (pt) 2015-04-01 2021-12-07 Akebia Therapeutics Inc Composições e métodos de tratamento de anemia
CN106727396A (zh) * 2016-11-22 2017-05-31 湖北广济药业股份有限公司 一种ⅱ晶型利奈唑胺片及其制备方法
CN109481412A (zh) * 2018-08-17 2019-03-19 扬子江药业集团北京海燕药业有限公司 一种ii晶型利奈唑胺片及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
AU767380B2 (en) * 1999-05-27 2003-11-06 Pharmacia & Upjohn Company Bicyclic oxazolidinones as antibacterial agent

Also Published As

Publication number Publication date
DE60136341D1 (de) 2008-12-11
KR20070094673A (ko) 2007-09-20
UA77654C2 (en) 2007-01-15
AU2001243243B2 (en) 2004-10-14
KR20020083185A (ko) 2002-11-01
PL201686B1 (pl) 2009-04-30
WO2001070225A3 (en) 2001-12-13
EA006772B1 (ru) 2006-04-28
BG107117A (bg) 2003-05-30
NO20024505D0 (no) 2002-09-20
PT1265608E (pt) 2008-12-15
CA2400118A1 (en) 2001-09-27
ECSP013979A (es) 2002-01-25
AR033357A1 (es) 2003-12-17
KR100786410B1 (ko) 2007-12-17
MY136370A (en) 2008-09-30
AU4324301A (en) 2001-10-03
PE20011126A1 (es) 2001-10-31
MXPA02009316A (es) 2004-04-05
YU69802A (sh) 2005-11-28
NZ521525A (en) 2004-02-27
NO20024505L (no) 2002-09-20
HRP20020765A2 (en) 2003-12-31
BR0108846A (pt) 2003-05-06
CN1208058C (zh) 2005-06-29
HK1054325A1 (zh) 2003-11-28
HUP0300378A2 (hu) 2003-06-28
EP1265608A2 (en) 2002-12-18
IL151788A0 (en) 2003-04-10
WO2001070225A2 (en) 2001-09-27
CN1418097A (zh) 2003-05-14
JP2003527424A (ja) 2003-09-16
CZ20023133A3 (cs) 2003-01-15
ES2312422T3 (es) 2009-03-01
TWI293028B (en) 2008-02-01
EP1265608B1 (en) 2008-10-29
ATE412413T1 (de) 2008-11-15
SK12092002A3 (sk) 2002-12-03
PL366067A1 (en) 2005-01-24
HK1054325B (zh) 2006-01-13
DK1265608T3 (da) 2008-12-08
ZA200207073B (en) 2003-12-03
HUP0300378A3 (en) 2004-11-29
PE20020499Z (es) 2002-07-12

Similar Documents

Publication Publication Date Title
EA200301250A1 (ru) Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры
NO20024891D0 (no) Farmasöytiske sammensetninger
EA200200571A1 (ru) Новая композиция и ее применение
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
DE69907977D1 (de) Pyrrolobenzodiazepine
BR0317682A (pt) Composição farmacêutica de liberação modificada
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
ATA244992A (de) Stabilisiertes pharmazeutisches mittel, enthaltend einen hmg-coa-reduktase-inhibitor wirkstoff
ITTO20010005A0 (it) Formulazione farmaceutica.
ATE428729T1 (de) Kovalent verbrückte insulindimere
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
EA200201006A1 (ru) Технология приготовления таблеток оксазолидинона
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
ES2184452T3 (es) Preparacion farmaceutica que contiene levotiroxina de sodio.
ATE285753T1 (de) Lysin enthaltende kautablette
DE60225686D1 (de) Paracetamol enthaltende tablette
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
ES2171018T3 (es) Uso de agentes inmunomoduladores.
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DK0427124T3 (da) Antacidatabletter
ES2172182T3 (es) Composiciones farmaceuticas que comprenden cefuroxima axetil.
EE200200391A (et) Farmatseutiline kompositsioon, mis sisaldab hüdrokarbüültuumaga ühendit
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
BG102638A (bg) Таблети с високо съдържание на фамцикловир
EP0948961A3 (de) Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM